Trial of Nivolumab With Chemotherapy as Neoadjuvant Treatment in Inflammatory Breast Cancer (IBC)

Completed · Phase 2

Conditions studied: Breast Cancer

In brief

Study of efficacy of nivolumab with neoadjuvant chemotherapy in patients with IBC

Key facts

Study ID
NCT03742986
Run by
NYU Langone Health
People needed
8
Starts
2019-05-02
Expected to finish
2023-06-12
Last updated by the study team
2023-12-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.